U.S. markets open in 1 hour 7 minutes
  • S&P Futures

    4,140.25
    +15.75 (+0.38%)
     
  • Dow Futures

    32,837.00
    +100.00 (+0.31%)
     
  • Nasdaq Futures

    13,095.00
    +63.50 (+0.49%)
     
  • Russell 2000 Futures

    1,919.60
    +5.00 (+0.26%)
     
  • Crude Oil

    89.11
    -1.39 (-1.54%)
     
  • Gold

    1,808.60
    -3.70 (-0.20%)
     
  • Silver

    20.45
    -0.03 (-0.13%)
     
  • EUR/USD

    1.0256
    +0.0039 (+0.38%)
     
  • 10-Yr Bond

    2.7970
    0.0000 (0.00%)
     
  • Vix

    22.12
    +0.83 (+3.90%)
     
  • GBP/USD

    1.2113
    +0.0037 (+0.31%)
     
  • USD/JPY

    134.8470
    -0.2690 (-0.20%)
     
  • BTC-USD

    23,159.41
    -109.66 (-0.47%)
     
  • CMC Crypto 200

    539.56
    -17.79 (-3.19%)
     
  • FTSE 100

    7,494.10
    +5.95 (+0.08%)
     
  • Nikkei 225

    27,819.33
    -180.63 (-0.65%)
     

3M to exit Neoplast, Neobun brands in Southeast Asia

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

July 1 (Reuters) - Industrial conglomerate 3M Co said on Friday it will exit its Neoplast and Neobun brands in Thailand and some other Southeast Asian countries, and sell manufacturing assets at its Ladlumkaew plant, as part of its strategic portfolio management.

The brands — part of the company's Consumer Health and Safety Division (CHSD) — and the assets from its Thailand-based Ladlumkaew plant will be sold to Selic Corp PCL, 3M said.

The St. Paul, Minnesota-based company did not disclose the terms of the deal, but said the sale will not have a material impact on its financial results.

"As part of ongoing strategic portfolio management, 3M has decided to exit these brands and prioritize other areas within its Consumer Health & Safety Division," 3M said.

Neoplast makes surgical tapes, dressings and first aid bandages, while Neobun makes menthol plasters for muscle pain.

The brands are sold primarily in Thailand and Southeast Asia and were a part of 3M's larger CHSD that includes sports and medical tapes, bandages and medicated products for the consumer and healthcare industry, according to the company.

3M also said its plan to sell the Ladlumkaew plant will impact about 250 employees in the country, and the affected employees are eligible for severance and outplacement assistance.

The U.S.-based company had acquired Neoplast in 2007. (Reporting by Ann Maria Shibu in Bengaluru; editing by Uttaresh.V)